Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs NEULAND LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PANACEA BIOTECH NEULAND LABS PANACEA BIOTECH/
NEULAND LABS
 
P/E (TTM) x -60.9 25.4 - View Chart
P/BV x 0.9 8.1 10.9% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 PANACEA BIOTECH   NEULAND LABS
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-23
NEULAND LABS
Mar-23
PANACEA BIOTECH/
NEULAND LABS
5-Yr Chart
Click to enlarge
High Rs1912,004 9.5%   
Low Rs107966 11.1%   
Sales per share (Unadj.) Rs75.1928.4 8.1%  
Earnings per share (Unadj.) Rs-5.5127.4 -4.3%  
Cash flow per share (Unadj.) Rs0.9168.6 0.5%  
Dividends per share (Unadj.) Rs010.00 0.0%  
Avg Dividend yield %00.7 0.0%  
Book value per share (Unadj.) Rs137.7774.8 17.8%  
Shares outstanding (eoy) m61.2512.83 477.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.01.6 124.3%   
Avg P/E ratio x-27.111.7 -232.5%  
P/CF ratio (eoy) x170.08.8 1,929.8%  
Price / Book Value ratio x1.11.9 56.5%  
Dividend payout %07.8 -0.0%   
Avg Mkt Cap Rs m9,14219,052 48.0%   
No. of employees `000NANA-   
Total wages/salary Rs m1,2652,018 62.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m4,59911,912 38.6%  
Other income Rs m51797 530.0%   
Total revenues Rs m5,11612,009 42.6%   
Gross profit Rs m472,718 1.7%  
Depreciation Rs m391528 74.1%   
Interest Rs m44131 34.0%   
Profit before tax Rs m1282,157 5.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m466522 89.1%   
Profit after tax Rs m-3371,635 -20.6%  
Gross profit margin %1.022.8 4.5%  
Effective tax rate %363.524.2 1,501.7%   
Net profit margin %-7.313.7 -53.4%  
BALANCE SHEET DATA
Current assets Rs m5,6237,609 73.9%   
Current liabilities Rs m3,2974,390 75.1%   
Net working cap to sales %50.627.0 187.1%  
Current ratio x1.71.7 98.4%  
Inventory Days Days596 922.7%  
Debtors Days Days481,109 4.3%  
Net fixed assets Rs m7,0288,189 85.8%   
Share capital Rs m61129 47.5%   
"Free" reserves Rs m8,3759,812 85.4%   
Net worth Rs m8,4369,941 84.9%   
Long term debt Rs m202742 27.2%   
Total assets Rs m12,71215,798 80.5%  
Interest coverage x3.917.5 22.2%   
Debt to equity ratio x00.1 32.0%  
Sales to assets ratio x0.40.8 48.0%   
Return on assets %-2.311.2 -20.6%  
Return on equity %-4.016.4 -24.3%  
Return on capital %2.021.4 9.3%  
Exports to sales %43.373.5 59.0%   
Imports to sales %24.415.1 161.3%   
Exports (fob) Rs m1,9928,750 22.8%   
Imports (cif) Rs m1,1241,804 62.3%   
Fx inflow Rs m1,9928,750 22.8%   
Fx outflow Rs m1,1911,804 66.0%   
Net fx Rs m8016,946 11.5%   
CASH FLOW
From Operations Rs m-4,2252,372 -178.1%  
From Investments Rs m4,303-615 -699.7%  
From Financial Activity Rs m-184-1,358 13.5%  
Net Cashflow Rs m-105403 -26.0%  

Share Holding

Indian Promoters % 73.6 32.8 224.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.0 29.1 3.3%  
FIIs % 0.3 22.7 1.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.4 67.2 39.3%  
Shareholders   47,091 27,723 169.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PANACEA BIOTECH With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Panacea Biotech vs NEULAND LABS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Panacea Biotech vs NEULAND LABS Share Price Performance

Period Panacea Biotech NEULAND LABS S&P BSE HEALTHCARE
1-Day -1.74% -1.12% 1.18%
1-Month -20.01% -11.56% -0.75%
1-Year 11.75% 269.91% 61.82%
3-Year CAGR -12.26% 43.81% 18.16%
5-Year CAGR -9.98% 59.26% 19.79%

* Compound Annual Growth Rate

Here are more details on the Panacea Biotech share price and the NEULAND LABS share price.

Moving on to shareholding structures...

The promoters of Panacea Biotech hold a 73.6% stake in the company. In case of NEULAND LABS the stake stands at 32.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Panacea Biotech and the shareholding pattern of NEULAND LABS.

Finally, a word on dividends...

In the most recent financial year, Panacea Biotech paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

NEULAND LABS paid Rs 10.0, and its dividend payout ratio stood at 7.8%.

You may visit here to review the dividend history of Panacea Biotech, and the dividend history of NEULAND LABS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.